346 related articles for article (PubMed ID: 15779048)
1. Persistence of acute infection with hepatitis B virus genotype A and treatment in Japan.
Suzuki Y; Kobayashi M; Ikeda K; Suzuki F; Arfase Y; Akuta N; Hosaka T; Saitoh S; Kobayashi M; Someya T; Matsuda M; Sato J; Watabiki S; Miyakawa Y; Kumada H
J Med Virol; 2005 May; 76(1):33-9. PubMed ID: 15779048
[TBL] [Abstract][Full Text] [Related]
2. Viral genotypes and response to interferon in patients with acute prolonged hepatitis B virus infection of adulthood in Japan.
Kobayashi M; Arase Y; Ikeda K; Tsubota A; Suzuki Y; Saitoh S; Kobayashi M; Suzuki F; Akuta N; Someya T; Matsuda M; Sato J; Takagi K; Miyakawa Y; Kumada H
J Med Virol; 2002 Dec; 68(4):522-8. PubMed ID: 12376960
[TBL] [Abstract][Full Text] [Related]
3. Response to long-term lamivudine treatment in patients infected with hepatitis B virus genotypes A, B, and C.
Kobayashi M; Suzuki F; Akuta N; Suzuki Y; Arase Y; Ikeda K; Hosaka T; Sezaki H; Kobayashi M; Iwasaki S; Sato J; Watahiki S; Miyakawa Y; Kumada H
J Med Virol; 2006 Oct; 78(10):1276-83. PubMed ID: 16927289
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of long-term interferon therapy in chronic hepatitis B patients with HBV genotype C.
Sakai T; Shiraki K; Inoue H; Okano H; Deguchi M; Sugimoto K; Ohmori S; Murata K; Nakano T
Int J Mol Med; 2002 Aug; 10(2):201-4. PubMed ID: 12119559
[TBL] [Abstract][Full Text] [Related]
5. Treatment of hepatitis B with lamivudine and tenofovir in HIV/HBV-coinfected patients: factors associated with response.
Jain MK; Comanor L; White C; Kipnis P; Elkin C; Leung K; Ocampo A; Attar N; Keiser P; Lee WM
J Viral Hepat; 2007 Mar; 14(3):176-82. PubMed ID: 17305883
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus genotypes and spontaneous hepatitis B e antigen seroconversion in Taiwanese hepatitis B carriers.
Kao JH; Chen PJ; Lai MY; Chen DS
J Med Virol; 2004 Mar; 72(3):363-9. PubMed ID: 14748059
[TBL] [Abstract][Full Text] [Related]
7. Differences of YMDD mutational patterns, precore/core promoter mutations, serum HBV DNA levels in lamivudine-resistant hepatitis B genotypes B and C.
Pan XP; Li LJ; Du WB; Li MW; Cao HC; Sheng JF
J Viral Hepat; 2007 Nov; 14(11):767-74. PubMed ID: 17927612
[TBL] [Abstract][Full Text] [Related]
8. Anti-hepatitis B virus efficacy of tenofovir disoproxil fumarate in HIV-infected patients.
Benhamou Y; Fleury H; Trimoulet P; Pellegrin I; Urbinelli R; Katlama C; Rozenbaum W; Le Teuff G; Trylesinski A; Piketty C;
Hepatology; 2006 Mar; 43(3):548-55. PubMed ID: 16496322
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus genotypes B and C do not affect the antiviral response to lamivudine.
Yuen MF; Wong DK; Sablon E; Yuan HJ; Sum SM; Hui CK; Chan AO; Wang BC; Lai CL
Antivir Ther; 2003 Dec; 8(6):531-4. PubMed ID: 14760886
[TBL] [Abstract][Full Text] [Related]
10. Response to long-term lamivudine treatment (up to 5 years) in patients with severe chronic hepatitis B, role of genotype and drug resistance.
Moskovitz DN; Osiowy C; Giles E; Tomlinson G; Heathcote EJ
J Viral Hepat; 2005 Jul; 12(4):398-404. PubMed ID: 15985011
[TBL] [Abstract][Full Text] [Related]
11. Virological outcomes in patients infected chronically with hepatitis B virus genotype A in comparison with genotypes B and C.
Kobayashi M; Akuta N; Suzuki F; Suzuki Y; Arase Y; Ikeda K; Hosaka T; Saitoh S; Kobayashi M; Someya T; Sato J; Watabiki S; Miyakawa Y; Kumada H
J Med Virol; 2006 Jan; 78(1):60-7. PubMed ID: 16299721
[TBL] [Abstract][Full Text] [Related]
12. Residual hepatitis B virus particles in liver transplant recipients receiving lamivudine: PCR quantitation of HBV DNA and ELISA of preS1 antigen.
Petit MA; Buffello-Le Guillou D; Roche B; Dussaix E; Duclos-Vallée JC; Féray C; Samuel D
J Med Virol; 2001 Nov; 65(3):493-504. PubMed ID: 11596084
[TBL] [Abstract][Full Text] [Related]
13. Should treatment of hepatitis B depend on hepatitis B virus genotypes? A hypothesis generated from an explorative analysis of published evidence.
Wiegand J; Hasenclever D; Tillmann HL
Antivir Ther; 2008; 13(2):211-20. PubMed ID: 18505172
[TBL] [Abstract][Full Text] [Related]
14. Change of hepatitis B virus genotypes in acute and chronic infections in Japan.
Kobayashi M; Ikeda K; Arase Y; Suzuki F; Akuta N; Hosaka T; Sezaki H; Yatsuji H; Kobayashi M; Suzuki Y; Watahiki S; Mineta R; Iwasaki S; Miyakawa Y; Kumada H
J Med Virol; 2008 Nov; 80(11):1880-4. PubMed ID: 18814241
[TBL] [Abstract][Full Text] [Related]
15. Frequent detection of hepatitis B virus variants associated with lamivudine resistance in treated South African patients infected chronically with different HBV genotypes.
Selabe SG; Song E; Burnett RJ; Mphahlele MJ
J Med Virol; 2009 Jun; 81(6):996-1001. PubMed ID: 19382250
[TBL] [Abstract][Full Text] [Related]
16. Higher efficacy of sequential therapy with interferon-alpha and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients.
Sarin SK; Kumar M; Kumar R; Kazim SN; Guptan RC; Sakhuja P; Sharma BC
Am J Gastroenterol; 2005 Nov; 100(11):2463-71. PubMed ID: 16279901
[TBL] [Abstract][Full Text] [Related]
17. Impact of highly active antiretroviral therapy (HAART) on the natural history of hepatitis B virus (HBV) and HIV coinfection: relationship between prolonged efficacy of HAART and HBV surface and early antigen seroconversion.
Miailhes P; Trabaud MA; Pradat P; Lebouché B; Chevallier M; Chevallier P; Zoulim F; Trepo C
Clin Infect Dis; 2007 Sep; 45(5):624-32. PubMed ID: 17682999
[TBL] [Abstract][Full Text] [Related]
18. Response to antiviral treatment in patients infected with hepatitis B virus genotypes E-H.
Erhardt A; Göbel T; Ludwig A; Lau GK; Marcellin P; van Bömmel F; Heinzel-Pleines U; Adams O; Häussinger D
J Med Virol; 2009 Oct; 81(10):1716-20. PubMed ID: 19697400
[TBL] [Abstract][Full Text] [Related]
19. Distinct geographic distributions of hepatitis B virus genotypes in patients with acute infection in Japan.
Yotsuyanagi H; Okuse C; Yasuda K; Orito E; Nishiguchi S; Toyoda J; Tomita E; Hino K; Okita K; Murashima S; Sata M; Hoshino H; Miyakawa Y; Iino S;
J Med Virol; 2005 Sep; 77(1):39-46. PubMed ID: 16032734
[TBL] [Abstract][Full Text] [Related]
20. A preliminary trial of lamivudine for chronic hepatitis B infection.
Dienstag JL; Perrillo RP; Schiff ER; Bartholomew M; Vicary C; Rubin M
N Engl J Med; 1995 Dec; 333(25):1657-61. PubMed ID: 7477217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]